An increased number of GATA3 gene copies were detectable in 218 (9.9%) of the 2,213 analyzable carcinomas, including 44 (2.0%) with GATA3 elevation, 71 (3.2%) with low-level amplification, and 103 (4.7%) with high-level amplification. Here, GATA3 is linked to carcinoma.